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ABSTRACT 
 
 
Characterization of Volatile and Metabolite Compounds Produced by Lactococcus lactis  
 
in Low-Fat and Full-Fat Cheddar Cheese Extract 
 
 
by 
 
 
Michael J. Young, Master of Science 
 
Utah State University, 2011 
 
 
Major Professor:  Dr. Robert E. Ward 
Department:  Nutrition, Dietetics, and Food Sciences 
 
 
This study was conducted to compare and contrast potential aroma compounds in 
the headspace and small molecule metabolites produced as a result of starter culture 
metabolism in a full-fat and low-fat cheddar cheese model system.  Past studies have 
indicated differences in the headspace flavor compound profiles between full-fat and 
low-fat Cheddar cheeses with no indication as to what compounds were produced as a 
result of starter culture metabolism.  
 Starter cultures were incubated in a Cheddar cheese extract environment that was 
made up of the water-soluble portion of Cheddar cheese with environmental conditions 
mimicking full-fat and low-fat Cheddar cheese by altering the levels of salt and milk fat 
globular membrane in the system.  Incubation times were up to 14 days at 30°C and 
samples were taken at days 0, 1, 7, and 14.  Headspace analysis was accomplished using 
solid phase micro-extraction coupled with GC-MS and small metabolites were monitored 
using metabolomic methods coupled with GC-MS.    
 iv 
Results indicate that the starter culture was responsible for an increase in the 
concentration of propan-2-one, heptan-2-one, 3-methylbutanal, heptanal, benzaldehyde, 
2-ethylhexanal, and dimethyl trisulfide in both the full-fat and low-fat medias when 
compared to their respective controls.  While heptanal was present at a higher 
concentration in the full-fat treatments compared to the low-fat treatments and 2-
ethylhexan-1-ol and isothiocyanato cyclohexane were present at higher concentrations in 
the low-fat treatments compared to the full-fat treatments. 
Principal component analysis for the headspace compounds showed a clear 
separation of the treatments with heptanal, p-cymene, nonan-2-one, and undecan-2-one 
contributing the most to the variation between the full-fat and low-fat samples, while 3-
methylbutanal, heptan-2-one, benzaldehyde, 2-ethylhexan-1-ol, 2,6-dimethylheptan-4-ol, 
and 3-methylbutanol contributed the most to the variation between the controls and 
treatments. 
The metabolomics data for both the bacteria and Cheddar cheese extract did not 
provide a clear separation between the full-fat and low-fat samples. 
(91 pages) 
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INTRODUCTION 
 
 
The CDC reported in 2008 that Colorado was the only state with a prevalence of 
obesity less than 20%.  There were 32 states with prevalence rates equal to or greater than 
25%.  This has been a cause of concern due to the health risks associated with obesity.  
Dieticians have suggested a reduction in total calories in the diet as a way to reduce 
obesity.    Recent dietary guidelines indicate that fat should account for less than 30% of 
the total energy intake in the American diet (McDonald 2000).  As a result of these 
guidelines, demand for low-fat (LF) and reduced-fat food alternatives has risen. 
According to the Code of Federal Regulations, Cheddar cheese is a high fat food.  
Most traditional Cheddar cheeses contain 9 grams of total fat per one ounce serving, 
which translates to 14% of the daily intake of total fat in a 2000 calorie diet.  As the 
consumer searches for food options, with this increase in awareness of the need to reduce 
total caloric intake due to fat, labels that contain a high amount of fat may deter purchase. 
The increased demand for lower fat alternatives to full-fat (FF) Cheddar cheese 
has resulted in the development of reduced-fat Cheddar cheese products.  The primary 
difference between reduced-fat Cheddar cheese and FF Cheddar cheese is the reduction 
of fat content.  The fat has to be replaced to maintain body and in most cases this is 
accomplished by increasing the moisture content. 
The reduction of fat produces a product that has a lower consumer acceptance due 
to its rubbery texture and its bland and bitter flavor (Banks 2004).  The flavor, aroma, and 
texture are important components of the overall sensory experience of Cheddar cheese.  
In 1998 the sales of LF and reduced-fat cheese accounted for 20% of the total cheese sold 
in United States supermarkets (Mistry 2001).  It is has been suggested that the growth of 
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LF and reduced-fat cheese may have stalled due to consumer demands for a higher 
quality product and the consumer’s memory of poor quality in the initial LF and reduced-
fat cheese products (Guinee and others 1998).  
The development of Cheddar cheese flavor is a complicated process that occurs 
primarily during ripening.  The main constituents of milk interact with native enzymes in 
the milk as well as added components such as rennet and starter culture to form volatile 
compounds.  Some of these products contribute to the overall flavor of the cheese, which  
is determined by not only whether or not certain compounds are found in the product but 
also by the proportion at which it is present compared to other compounds (Fox and 
Wallace 1997).   
The complex nature of cheese makes the monitoring of aroma compounds 
produced by specific bacterial strains very difficult, especially when alterations in 
important intrinsic parameters like pH, redox, salt, and lactate levels are considered.  If 
conducting research with natural cheese, blocks of each treatment would be required and 
the aroma compounds contributed by any specific bacteria would be hard to distinguish 
from other sources. To overcome this problem, a Cheddar cheese model system was 
developed that allows for the alteration of parameters important to both flavor production 
and bacterial growth (Diaz-Muniz and others 2006).  Cheddar cheese extract (CCE) is 
essentially the aqueous phase of cheese and it is hypothesized that the microorganisms 
contributing to the flavor of cheese utilize components in this phase.  The CCE can be 
inoculated with the bacterium of interest and grown under very specific conditions while 
monitoring the effect of that bacterium on aroma production.   
The hypothesis of this study is: 
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Lactococcus lactis incubated in CCE, adjusted to mimic LF and FF 
conditions, will produce different volatile headspace (HS) and metabolite 
profiles. 
The research aims addressed in this thesis are: 
1. Characterization of volatile compounds in the HS of both LF and FF CCE 
inoculated with Lactococcus lactis using solid phase micro-extraction (SPME) 
gas chromatography mass spectrometry (GC-MS). 
2. Characterization of small molecule metabolites in the bacteria and the media 
using metabolomics techniques coupled with GC-MS. 
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LITERATURE REVIEW 
Cheddar Cheese Flavor 
 
Flavor production in Cheddar cheese occurs primarily during the ripening stage of 
the cheese making process.  During the ripening stage, key components of the cheese are 
broken down to produce different flavor compounds.  This process occurs as a result of 
both added components, such as starter cultures and rennet, and components not 
intentionally added such as non-starter lactic acid bacteria (NSLAB) and native enzymes 
of the milk system.  Key flavor precursors include proteins, fats, citrate, and residual 
lactose.  Flavor development in cheese results from a combination of microbial and 
biochemical activities that lead to the formation of a heterogeneous mixture of volatile 
and nonvolatile flavor compounds (Fox and Wallace 1997).  This process takes time and 
is dependent on intrinsic and extrinsic factors including temperature, redox potential, pH, 
and salt/moisture (S/M) (Fox and others 2000).    
The characteristic Cheddar cheese flavor has not been attributed to a single 
compound; rather it is a result of a balance between a variety of flavor compounds in the 
cheese.  This has been termed the “component balance theory” which states that the 
Cheddar cheese flavor comes from the correct proportion or balance of all the flavor 
compounds in the Cheddar cheese (Mulder 1952).  To date, there has not been a 
successful synthetic recreation of the Cheddar cheese flavor, which indicates its 
complexity.  
Although the overall desirable flavor of Cheddar cheese has not been defined in 
exact chemical makeup, the characterizations of off flavors have been identified with 
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moderate success.  The off flavors arise due to a disproportional amount of certain 
compounds in the cheese.  For example, bitterness mainly arises due to an increase in 
hydrophobic peptides, rancidity arises due to fatty acids, and fruitiness is due to ester 
formation (Fox and others 2000). 
 
Low-Fat Cheddar Cheese Flavor 
Low-fat cheese has a characteristic lack of desirable flavor intensity when 
compared to its FF counterpart.  Instead, the flavor profile of LF cheese is dominated by 
off flavors, characterized as bitter, meaty, brothy, unclean, and barnyard like (Banks et al 
1992).  These off flavors are likely due to an imbalance of flavor compounds (Mistry 
2001).  Three proposed theories explain the loss of characteristic FF Cheddar flavor in 
the LF product.   
The first theory proposes starter culture physiology and the resulting metabolic 
end product profiles are the same in all cheeses, but sensory perception of those 
metabolites is altered by differences in the physico-chemical environment (e.g. fat, 
moisture, or S/M values).  
Research has shown that fat in food plays an important role in the delivery of 
flavor (Li and others 1997; Prindiville and others 2000; Roberts and others 2003; 
Carunchia Whetstine and others 2006).  Most flavor compounds are classified as 
nonpolar and hydrophobic.  Being classified as such, flavor compounds tend to associate 
with the fat portion in food systems (Relkin and others 2004). Van der Walls and 
hydrophobic interactions characterize the interactions between fat and hydrophobic flavor 
compounds (Plug and Haring 1993).   
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Recent research conducted by Carunchia Whetstine and others (2006) indicates 
that the aroma compounds in Cheddar cheese are present more in the aqueous phase of 
the cheese rather than the fat phase.  In this study fat was removed from Cheddar cheese, 
using a novel process, and the aroma compounds of both the remaining cheese and 
removed fat were tested.  The results showed that aroma compounds were present more 
in the cheese than the fat indicating that the fat does not play as critical a role in binding 
aroma compounds as previously thought. 
Each flavor compound has different physical and chemical properties and only 
those compounds that are present in a high enough concentration to stimulate olfactory 
receptors are above sensory threshold and therefore sensed by the consumer (Carunchia 
Whetstine and others 2006).  During the mastication process, the release of flavor and 
thus the sensory perception of aroma compounds are dependent on the rate of release 
from the cheese matrix, which is influenced by the fat content (Delahunty and others 
1996).   An increase in fat, holding the flavor compound concentration constant, would 
increase the sensory threshold due to the added interactions between flavor and fat.  
These interactions decrease the available amount of flavor in the HS of the sample and 
therefore a lower concentration of flavor compounds is needed to elicit a similar sensory 
threshold in a LF product due to the decreased availability of fat flavor interactions 
(Carunchia Whetsine and others 2006).  
The second theory proposes microbial physiology itself, and thus overall 
metabolism, is altered by differences in the physico-chemical environment in ways that 
affect the production of flavor and aroma active metabolites.   
The change in the physico-chemical environment of LF cheese could alter the 
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overall metabolism of the starter culture, which would in turn alter the proportion of 
flavor compounds of the final product.  Thus, any difference in the proportion of flavor 
compounds found in the FF and LF cheeses would contribute to the differing flavor 
profile between the two products.  Any differences in metabolic activity of the starter 
culture in FF versus LF cheese would likely be due to the increase in the moisture and the 
reduction of the S/M in the LF cheese when compared to the FF cheese.  Table 1 
demonstrates the differences between FF and LF Cheddar cheese physico-chemical 
environment conditions. 
Research conducted by Milo and Reineccius (1997) showed a difference in the 
proportions of flavor compounds between FF and LF Cheddar cheese.  They found that 
the meaty/brothy off-flavor of the LF Cheddar cheese was caused in part due to the 
increased amounts of methional, furaneol, and especially homofuraneol.  They proposed 
that this change came about due to the increased bacterial growth as a consequence of 
increased moisture. 
 
Table 1 Differences of full-fat and low-fat Cheddar cheese  
 Full-fat Low-fat 
Moisture (%) 37.0 50.3 
Fat (%) 33.8 7.00 
Salt (%) 1.76 1.85 
Salt in moisture (%) 4.75 3.68 
pH 5.26 5.21 
*Values were taken from the analysis of full-fat and low-fat Cheddar cheese used in 
Cheddar cheese extract preparation 
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The third theory proposes the physico-chemical environment of LF cheese may 
produce major changes in the gross microbiology of cheese. 
Broadbent (2009) showed that there was a difference in the growth of both starter 
culture and NSLAB in FF and reduced-fat and LF Cheddar cheeses.  The growth of the 
starter in the reduced-fat and LF cheeses showed signs of stability up to 3 months before 
showing signs of decline, while the starter cultures in the FF had declined by at least two 
orders at 3 months.  The growth of the NSLAB in the LF cheese reached levels of 106 by 
six weeks while in FF cheese these levels were not attained by the 3 to 6 month time 
period.  The difference in the growth of both the starter culture and the NSLAB in the FF 
and LF Cheddar cheese are most likely due to the differences in the environment shown 
in Table 1.  The difference in the growth of both the starter culture and the NSLAB in the 
FF versus the LF cheese would likely result in a difference in the metabolism of the 
microorganisms and consequently a shift in the flavor compounds.   
  The most likely scenario is that all three of these effects play a role in the 
development of differences in FF and LF Cheddar cheese.  The microbial growth of both 
the starter cultures and the NSLAB are affected by the alteration of the environment 
found in LF cheese leading to an increase in growth and possible changes in metabolic 
activity.  The changes in growth lead to an alteration in the proportion of the flavor 
compounds found in the LF cheese when compared to the FF cheese due to alteration of 
metabolic activity.  To further complicate the problem, fat, which may act to mask off 
flavors in FF cheese, is replaced with water in LF cheese. The reduction of fat decreases 
the flavor threshold of flavor compounds, making potentially undesirable compounds 
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perceived by the consumer.  This increased perception of undesirable compounds leads 
to an unsatisfactory sensory experience for the consumer. 
  
Lactococcus lactis Characteristics 
 
Lactococcus lactis is a common starter culture that is added to milk in the 
production of Cheddar cheese.  Some of the benefits of L. lactis strains include rapid acid 
production, salt sensitivity, and ripening activity (Fox and others 2000).  Steady acid 
production throughout the cheese making process ensures the suppression of undesirable 
bacterial growth (Beresford and Williams 2004). L. lactis growth in an hour reaches 
levels greater than 108 cfu /g.  As cheese ripens, the L. lactis levels decrease to levels of 
107 to 104 cfu/g (Beresford and Williams 2004).    
Hassan and Frank (2001) describe the characteristics of L. lactis. L. lactis is cocci 
and usually occurs in chains.  They are homofermentive when grown in milk with 95% of 
their end products being lactic acid.  Growth occurs at 10ºC but not at 45ºC.  They are 
weakly proteolytic and can use milk proteins and lactose for growth.  They hydrolyze 
milk casein by the extracellular proteinase PrtP.  In addition, they can produce acid from 
lactose, galactose, maltose, and ribose and can grow in the presence of 4% salt. 
 
Flavor Production of Lactococcal Strains 
 
Starter cultures in Cheddar cheese have the primary role of reducing the pH by 
producing lactic acid from lactose.  The production of flavor compounds by starter 
cultures occurs as a result of the major biochemical events during the cheese ripening 
process.  These processes are categorized into four groups: (1) glycolysis of residual 
lactose and further catabolism of lactic acid, (2) catabolism of citrate, (3) lipolysis and the 
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subsequent catabolism of free fatty acids, and (4) proteolysis and the catabolism of 
amino acids (Fox and others 2000).  The importance of starter cultures role in the 
development of flavor was shown by Reiter and others (1966) where the absence of 
Cheddar flavor was shown in glucono delta-lactone acidified cheese and typical Cheddar 
cheese flavor was shown in starter culture only cheese. 
 
Lactose and citrate metabolism 
The fermentation of lactose by L. lactis primarily produces lactate, which is 
accomplished via glycolysis.  Lactate contributes to acidic flavor, especially in young 
cheeses (McSweeney and Sousa 1999).  The branch point of potential flavor compounds 
in the production of lactate is pyruvate, a metabolic intermediate.  Potential flavor 
compounds produced from pyruvate include acetoin, formate, acetaldehyde, ethanol, and 
acetate.  Research conducted by Melchiorsen and others (2000) showed that the 
production of formate, acetate, and ethanol by L. lactis was dictated by the concentration 
of lactose present.  Initially the lactose concentration is high enough to promote homo-
fermentation of lactose to L-lactic acid, but as the concentration of lactose decreases 
during the ripening, the production of formate, acetate, and ethanol along with L-lactic 
acid occurs.  
Lactococcal strains that are citrate positive have the ability to metabolize citrate in 
the presence of a fermentable sugar to acetate, diacetyl, acetoin and 2, 3-butanediol (Fox 
and others 2000). According to Curioni and Basset (2002) these compounds have been 
identified as contributing flavor compounds to Cheddar cheese.  Citrate is a minor 
constituent of milk with a majority of it lost in the whey.  Cheddar cheese contains 0.2%  
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Table 2. Some potential flavor byproducts of lactose and citrate metabolism 
Compound Flavora 
Acetaldehyde Sweet, pungent 
3-Hydroxybutan-2-one Sour milk 
Butane-2,3-dione (diacetyl) Cheesy, caramel 
Acetic acid Vinegar 
Ethanol Dry dust 
a(Curioni and Basset 2002) 
 
 
to 0.5% (wt/wt) citrate (McSweeney and Fox 2004).  Table 2 contains some potential 
aroma compounds resulting from fermentation of lactose and citrate. 
 
Fatty acid metabolism 
Fatty acids in milk come primarily in the form of triacylglycerols.  In order for the 
fatty acid to contribute to the flavor of the cheese it first be acted upon by a lipase or 
esterase to release the fatty acid from the glycerol backbone.  Lipolytic agents come from 
6 sources: milk, rennet, starter bacteria, secondary starter microorganisms, NSLAB, and 
exogenous lipase preparations (Collins et al 2004).   Milk fat has a high proportion of 
fatty acids that are either short or medium length that when liberated contribute directly 
to the flavor of the cheese (McSweeney and Sousa 1999).  Fatty acids can be substrates 
for further catabolic reactions, which produce methyl ketones, secondary alcohols, 
lactones, ethyl esters, aldehydes, acids, and alcohols.  Table 3 lists some potential flavor 
compounds and their respective flavor and Figure 1 shows the potential pathways 
followed to make these flavor compounds. 
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Table 3. Some potential flavor byproducts of fatty acid metabolism 
Class Compound Flavora 
Free fatty acid Butanoic acid Rancid, cheesy 
 Hexanoic acid Pungent 
 Octanoic acid Wax, goat, musty 
Methyl ketone Heptan-2-one Fruity, foral, musty 
 Propan-2-one Fruity, foral, musty 
 Nonan-2-one Fruity, foral, musty 
Secondary alcohol Propan-2-ol  
 Butan-2-ol  
 Octan-2-ol  
Lactone δ-Decalactone Peachy, coconut 
 γ-Decalactone Coconut 
Ethyl ester Ethyl butyrate Bubble gum, fruity 
 Ethyl hexanoate Young cheese 
 Ethyl octanoate Fruity 
Aldehyde Pentanal Chemical 
 Heptanal Soapy 
 Nonanal Green, fatty 
Alcohol Propan-1-ol Sweet (candy) 
 Pentan-1-ol Fruity 
aCurioni and Basset 2002 
 
 
Proteolysis and the catabolism of amino acids 
Proteolysis in ripening cheese comes primarily from the following sources: 
coagulant, indigenous milk proteases, starter culture proteases, and NSLAB proteases.  
Initially in the cheese making process, the primary hydrolysis of milk proteins is 
accomplished by the action of the coagulant and to a lesser extent by the native milk 
enzyme, plasmin.  The products of the initial hydrolysis are large peptides which are 
further broken down by action of the coagulant protease and enzymes contributed by the 
starter and NSLAB.  Proteinases and peptidases of the starter culture and NSLAB further 
hydrolyze the peptides into shorter peptides and amino acids (McSweeney and Sousa 
1999).   
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Figure 1. Potential pathways of fatty acid flavor development 
Highlighted compounds contribute to cheese flavor. 
 
 
Amino acids are further metabolized to form additional compounds that 
contribute to the flavor.  According to a review by Yvon and Rijnen (2001), aromatic 
amino acids (phenylalanine, tyrosine, tryptophan), branched-chain amino acids (leucine, 
isoleucine, and valine), and methionine are major precursors to important cheese flavor 
compounds.  There are 2 mechanisms by which amino acids are degraded by lactic acid 
bacteria, the first mechanism involves the cleaving off of amino acid side chains 
catalyzed by amino acid lyases, and the second method involves amino acid 
aminotransferases (Yvon and Rijnen 2001).    
The use of amino acid lyases in L. lactis is primarily used in the degradation of 
methionine, although this is not believed to be the primary method of the degradation 
methionine in this organism (Yvon and Rijnen 2001).  The two enzymes exhibiting lyase 
Aldehydes 
hydroperoxides 
Hydroperoxide 
lyase 
Acids 
Unsaturated fatty acids 
Free fatty Acid 
Ethyl esters 
β-oxidation 
4- or 5-hydroxyacids 
γ or δ Lactones 
Triacylglyceride 
Fatty acid 
Ethanol 
β-oxidation 
β-ketoacids 
Methyl ketones 
Secondary 
alcohols 
Alcohols 
Lipolytic activity 
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activity in L. lactis are cystathionine-β-lyase and cystathionine-γ-lyase (Curtin and 
McSweeney 2004). cystathionine-β-lyase catalyzes the conversion of cystathionine to 
homocysteine, pyruvate, and ammonia, while cystathionine-γ-lyase catalyzes the 
conversion of cystathionine to cysteine, α-keto butyrate, and ammonia (Curtin and 
McSweeney 2004).  
Aminotransferases catalyze the transfer of the amino group from an α-amino acid 
to an α-keto acid (Curtin and McSweeney 2004).  Often the α-keto acid acceptor is α-
ketoglutarate, which is transformed to glutamate upon reaction with an amino acid (Yvon 
and Rijnen 2001).  Aminotransferases are pryridoxal-5’-phosphate dependent enzymes 
that have broad substrate specificity and can catalyze reverse reactions (Weimer and 
others 1999).   
There appears to be three types of aminotransferases found in L. lactis bacteria, 
branched chain amino acid aminotransferase and aromatic amino acid aminotransferase 
(Yvon and Rijnen 2001). branched chain amino acid aminotransferase uses the following 
substrates Ile, Leu, Val, and Met, while aromatic amino acid aminotransferase uses Leu, 
Tyr, Phe, Trp, and Met.  The resulting α-keto acid products are further degraded to form 
potential flavor compounds.  Table 4 contains some potential flavor compounds that 
could originate from amino acids. 
 
Environmental Conditions 
The intent of this study is to monitor the aroma compound production of L. lactis 
in CCE under FF and LF conditions.  The variables that will differ between the FF and  
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Table 4. Some potential flavor compounds from amino acid metabolism 
Class Compound Flavora 
Aldehyde 3-Methyl butanal Slightly caramel, nutty 
 2-Methyl propanal Floral 
Alcohol 3-Methyl-1-butanol Alcoholic, green 
 3-Methyl-2-buten-ol Cheese, fruity, green 
 Phenylethanol Rosey 
Acid 1-Methyl propanoic acid  
 3-Methyl butanoic acid Swiss cheese 
Other Indole stable 
 Skatole Fecal 
 2-Isopropyl-3-
methoxypyrazine 
Earthy 
 Methional Baked potato 
 Methanethiol Sulfury 
 Dimethylsulphide Cabbage like 
 Dimethyltrisulfide Putrid 
 Dimethyltetrasulfide Putrid 
 p-Cresol Cowy, barny 
aCurioni 2002 
 
the LF CCE will be fat and S/M.  The following paragraphs describe the effects on flavor 
caused by altering the ripening temperature, S/M, and fat level. 
 
Ripening temperature 
 
Temperature is a major factor in the rate of biochemical reactions including 
enzymatic reactions.  The growth of the starter cultures is also dependent on ripening 
temperature.  The temperature used in the ripening of the cheese is a tradeoff between the 
growth of starter culture (good) and the growth of spoilage bacteria (bad).  The elevation 
of temperature can be used as a method to accelerate ripening, but risks skewing 
microbial population dynamics, as indicated above.  McSweeney and others (1996) 
showed that for Cheddar cheeses ripened at 8, 12, and 16ºC, the 16ºC ripened cheese 
exhibited the highest flavor score. 
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 Salt level 
The use of salt as a means of food preservation dates to pre-historic times.  The 
S/M in cheese plays several critical roles in the development of the cheese.  The added 
salt helps to determine the final pH of cheese by reducing starter culture metabolism.  
The salt also affects the overall flavor and texture by influencing proteolysis (Guinee and 
Fox 2004).   
Lawrence and others (1984) have suggested a S/M value of 4% to 6% in the 
grading of premium New Zealand Cheddar for long term ripening.  The increase of water 
associated with the decrease in fat in LF cheeses causes a reduction in the S/M to be as 
low as 3.5%.  Mistry and Kasperson (1998) studied the effect of varying salt 
concentrations of reduced-fat cheeses on bacterial growth, pH, and proteolysis during the 
ripening process.  They made reduced-fat Cheddar cheese with 2.7%, 3.7%, and 4.5% 
S/M and allowed them to ripen for 24 weeks testing the pH, microbial count, and 
proteolysis at 1, 4, 12, and 24 weeks. Their results showed a decrease in the microbial 
count of all varying level of S/M during the 24 week ripening period with a greater 
decrease in the microbial count in the 4.5 compared to the 2.7 and 3.7% S/M.  The pH of 
the cheese was also affected by the salt concentration.  The pH was lower in the 2.7% 
S/M and increased with an increase in salt, indicating an increase in the microbial activity 
in the low salt conditions.   
In LF cheese the S/M contained in the final product is decreased due to the 
increase in water to the product.  Salt is used as a method of keeping the bacterial growth 
in the cheese to a desirable level.  In LF cheese the growth and metabolic activity of the 
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starter culture as well as NSLAB maybe accelerated.  Off flavors can be observed 
potentially as a result of the increased bacterial growth and activity.  
 
Volatile and Metabolite Molecule Identification  
The following paragraphs detail the methods that were used in the identification 
of both the aroma volatiles and the small molecules.  In both methods the detection 
method is the same but the extraction and derivatization processes differ. 
 
Headspace solid phase micro-extraction  
In a review of applications of SPME Kataoka and others (2000) describe SPME 
as a solvent less extraction method in which a silica fused fiber is placed above the HS of 
the sample to trap volatiles.  The volatile compounds then partition to the fiber until 
equilibrium is achieved amongst the three phases in the system, fiber, HS, and sample or 
a predetermined amount of time has elapsed.  The fiber is then removed and inserted into 
the analytical instrument, such as liquid chromatograph or GC.  The use of SPME can 
greatly reduce the sample preparation time as well as eliminate potentially toxic solvents 
used to isolate compounds of interest as compared to other sample preparation techniques 
such as liquid-liquid or solid phase extraction.  A limiting factor in the use of SPME in 
volatile analysis is the selectivity of the fiber chosen for analysis, as the analytes obtained 
from the sample may not be a complete representative of all the volatile compounds in 
the HS.  The selectivity of different fibers is specific for certain types of compounds 
based primarily on the polarity and size of the compounds of interest.  Polar compounds 
are absorbed by polar fibers and likewise the same is true for nonpolar compounds, which 
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Figure 2. Comparison of polarity and retention of solid phase micro-extraction 
fibers: polydimethylsiloxane (PDMS), carboxen/polydimethylsiloxane (CAR/PDMS), 
divinylbenzene/carboxen/polydimethylsiloxane (CVB/CAR/PDMS), polyacrylate (PA), 
polydimethylsiloxane/divinylbenzene (PDMS/DVB), carbowax/divinylbenzene 
(CW/DVB), carbowax/templated resin (CW/TPR)  
 
 
are absorbed by nonpolar fibers.  In Figure 2, the different fiber types are shown with 
their relative polarity (Kataoka and others 2000). 
The use of HS SPME has been used in the analysis of dairy products. Chin and 
Rosenberg (1997) used HS SPME to compare the HS of FF and reduced-fat Cheddar 
cheeses.  Lee and others (2007) used HS SPME to monitor sulfur containing compounds 
in Cheddar cheese products.  
 
Metabolomics 
Metabolomics is an emerging field of study in which the small organic molecules 
of the system in question can be monitored.  The metabolomic method that was used in 
this study involves a quenching of the cells and media to bring about a halt in cellular 
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processing; this is typically done with methanol (Pieterse and others 2005).  The 
intracellular components of the cell are then extracted from the cells using a chloroform 
solution (Tian and others 2009).  The solution is then centrifuged and the supernatant 
consisting of the methanol is then taken and dried.  In order to volatilize the small 
molecules the dried sample is first subjected to an oximation reagent followed by a 
silylation step (Koek and others 2006).  The sample is then run through a GC-MS to 
separate and identify the metabolites.  Past research has shown that the use of oximation 
and syliation is a powerful tool to derivatize alcohol, aldehyde, acid, and amino groups of 
metabolites (van der Werf and others 2005).   
 
Gas chromatography mass spectrometry  
 
GC-MS is a method to first separate the analytes of interest by use of the GC, 
followed by the identification of the analytes using MS.  The compounds are separated in 
a capillary column in which the inside has been coated with a liquid stationary phase.  
The compounds are introduced into the column and a flow of gas pushes the compounds 
through the column.  The separation occurs as the analytes that have an increased affinity 
for the stationary phase will move slower than the compounds with a decreased affinity 
for the stationary phase.  The MS detects the compound by fragmenting the compound 
and measuring the produced fragments.  The peaks detected are then identified by 
comparison to authentic standards and libraries.  
 
Automated mass spectral deconvolution and identification system  
Automated Mass Spectral Deconvolution and Identification System (AMDIS) is a 
freely available computer program that extracts spectra of individual components in a 
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GC/MS data file and identifies target compounds by matching the spectra to that of the 
spectra in a target library.  AMDIS works by conducting these four steps: noise analysis, 
component perception, deconvolution, and compound identification (Stein 1999). 
 
SpectConnect 
 
SpectConnect is a freely available service found at the website 
http://spectconnect.mit.edu.  An example of the use of SpectConnect is given by 
Styczynski and others (2007).  This service tracks potential known and unknown 
metabolites or flavor compounds across replicates and different sample conditions 
without the use of reference spectra.  SpectConnect compares every spectrum in each 
sample to each spectra in every other sample.  Compounds are conserved across the 
replicates and different treatments by having similar mass spectrum and retention times.  
Stycznski and others (2007) hypothesized that the important compounds will be 
conserved across most or all replicates, while the noise will not be conserved.  Figure 3 
shows the process in which SpectConnect finds potential biomarker candidates that 
would otherwise not be analyzed due to a deficient library.  
SpectConnect requires the use of AMDIS to deconvolute the GC-MS 
chromatogram and a .ELU file is downloaded to the site.  SpectConnect also requires that 
replicates for each condition be performed.  The output obtained from the site includes 
retention time, relative abundance, integrated signal, and base peak for each compound 
analyzed.   
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Figure 3.  A representation of the SpectConnect process (Styczynski and others 2007). 
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MATERIALS AND METHODS 
 Cheddar Cheese Extract Make Procedure  
 
Cheddar cheese extract was produced by extracting the water soluble portion of 
the cheese matrix.  The cheese used as the starter material for the CCE in this project was 
a LF Cheddar cheese variety produced in the Gary Haight Richardson Dairy Products 
Laboratory at Utah State University.  The composition of the cheese can be seen in Table 
1.  The cheese was ripened to a point at which the lactose was below detectable limits, 
which took 6 weeks, to produce a medium that would imitate ripened cheese. 
The first step to make the CCE was to shred the ripened cheese and add it along 
with distilled water to a steam jacketed vat in a 1:2 ratio of cheese to water.  The mixture 
was then heated slowly to 50ºC with constant stirring to prevent burning and held or 20 
minutes.  The cheese came together and formed a dough like structure and was then 
removed from the mixture and discarded.   
The liquid portion then went through a series of filtration steps.  The first step was 
a diafiltration step using an ultrafilter, where the permeate was kept and the retentate was 
returned back to the filtration system, where with added distilled water it continued to be 
filtered until the permeate appeared to be mostly water.  The pore size of the ultrafilter 
excluded any large molecules such as proteins from entering the permeate while allowing 
small molecules such as lactose to pass.  The permeate from the ultrafiltration step was 
then concentrated using reverse osmosis, where the water was removed as the permeate 
and the retentate cycled through the filter to further concentrate the extract.  This process 
continued until the reverse osmosis membranes reached maximum capacity due to the 
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decrease in water.  The retentate was then collected and frozen.  The reverse osmosis 
process concentrated the CCE to 1.6 X concentration.  Figure 4 outlines the CCE make 
procedure. 
 
Milk Fat Globular Membrane Make Procedure 
 
Milk fat globular membrane in the original cheese was lost as a result of the 
filtration process during the CCE production.   MFGM was isolated from buttermilk 
produced at West Point Dairy Products, LLC (Hyrum, Utah).  The isolation of MFGM 
was accomplished using a method similar to Sachdeva and Buchheim (1997).  The 
buttermilk was heated to 36.5ºC then a 20% (wt/wt) solution of calcium chloride in water 
was added to the buttermilk in the amount of 0.1% (wt/wt) of the total buttermilk.  The 
mixture was then incubated for 30 minutes at 36.5ºC and rennet was added at 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Cheddar cheese extract make procedure. 
 
Shred six week old low-fat Cheddar cheese 
 
Add cheese to water in vat 
(2:1 water to cheese ratio (w/w)) 
 
Slowly heat up to 50ºC with constant stirring 
 
Hold at temperature for 20 minutes with continued stirring 
 
Strain the liquid to remove any solid cheese material 
 
Filter liquid through ultrafilter reserve permeate 
 
Reverse osmosis to further concentrate the CCE 
 
Freeze 
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concentration of 0.03% (wt/wt) to the mixture.  The curd was allowed to settle 
overnight at refrigeration temperature.  The top layer was siphoned off and reserved.  
Distilled water was added to the curd and the top layer was again siphoned off after the 
curd had sufficiently settled.  The siphoned top layers were then filtered through a 100K 
filtration unit produced by Millipore (Billerica, MA).  The retentate was concentrated and 
subjected to a 2X difiltration process to remove excess lactose.  The retentate was then 
freeze dried and stored in a -80ºC freezer.  Figure 5 shows the make procedure of the 
MFGM. The amount of MFGM to add to both the FF and LF samples were determined 
from the amount of fat in the original cheese and the calculations can be found in Table 5. 
 
 
 
  
 
  
 
 
    
  
 
 
 
 
  
 
Figure 5. Milk fat globular membrane make procedure. 
 
 
Heat buttermilk to 36.5ºC 
 
Addition of calcium chloride 
(0.1% of buttermilk as a 20% CaCl solution) 
 
Allow to stand for 30 minutes 
 
Add rennet 
(30 ml rennet/100 L buttermilk) 
 
Allow curd to settle overnight at refrigeration temperatures 
 
Siphon off top layer 
 
Wash curd with distilled water and repeat siphoning after sufficient settling 
 
Ultra-filter top layer 
 
2X diafilter 
 
Freeze dry 
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Table 5. Milk fat globular membrane calculations in full-fat and low-fat samples 
 
 
 
 
 
 
 
 
*Percentages were taken from Keenan and Mather (2006). 
 
Cheddar Cheese Extract Preparation for Runs 
 
 The CCE media is primarily made up of the 1.6 X CCE and distilled water.  Each 
run had 500 ml of 1.6 X CCE and 300 ml of distilled water.  The dried MFGM was added 
to half of the distilled water (150 ml) and autoclaved at 237ºF for 10 min.  The salt, lactic 
acid, and lactose was added to the remaining distilled water (150 ml) and mixed.  The 
500 ml of 1.6 X CCE was then added to the salt, lactic acid, lactose, and water mixture 
and sterilized by passage through a 0.45 micron filter (Thermo Fisher Scientific, 
Waltham, MA).  The MFGM mixture was then added to the filtered mixture to make the 
final CCE media.  The CCE media was then added to the fermenters and the pH was then 
adjusted to 5.1 and maintained throughout the fermentation. 
 
Starter Culture Preparation 
 
 Lactococcus lactis M70 used in this study was obtained from Danisco and was 
 Low-fat Full-fat 
%fat in cheese 6% 33% 
Fat amount in 1000 g cheese 60 g 330 g 
Total phospholid (0.8% of fat is 
phospholipid*) in 1000 g cheese 0.48 g 2.64 g 
PL associated with the MFGM (65% of PL 
associated with MFGM*) in 1000 g cheese 0.312 g 1.716 g 
Total MFGM (Composition of MFGM 25% 
PL and 70% protein*) in 1000 g cheese 1.1856 g 6.5208 g 
MFGM % in cheese* 0.11856% 0.65208% 
Amount of  cheese equivalent to 1 liter of 
CCE 2000 g 2700 g 
MFGM % in CCE 0.237% 1.76% 
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chosen for use in this study due to its use in a 2006 LF platform project (Drake and 
others 2010).  A stock culture was maintained frozen at -80ºC and working cultures were 
prepared by adding 0.1% of the frozen culture to M17 lactose broth and incubating at 
30ºC for 24 hours.  0.1% of the M17 lactose broth was then transferred to UHT milk and 
incubated for 24 hours at 30ºC, then used to inoculate (2%, vol/vol) 50 ml of 1 X CCE 
with 2% lactose and incubated for 24 hours at 30ºC.  The inoculated CCE was then 
centrifuged at 3000 X G and the CCE was drained off.  The remaining bacterial pellet 
was then re-suspended in 0.1% peptone buffer prior to inoculation of the CCE in a 
Biostat B Plus fermenter (Sartorius Stedim Biotech, Aubagne, France).  
 
Experiment Design 
 
 Two cheese environments were created, LF treatment (LFT) and FF treatment 
(FFT).  The S/M and MFGM level were adjusted in the media to reflect the values in the 
LF and FF cheese environments.  The lactate and pH were also adjusted to that of the 
cheese environment.  Table 6 shows the environmental conditions of the LF and FF 
model. 
 
Table 6. Cheese environmental conditions 
Environmental condition Low-fat model Full-fat model 
S/M (%)a 3.7% 4.75 
MFGM 0.12% 0.88% 
Lactose 0.21% 0.21% 
Lactatea 5500 ppm L-lactate 5500 ppm L-lactate 
 600 ppm D-lactate 600 ppm D-lactate 
Temperature 30ºC  30ºC  
pHb 5.1 5.1 
aReflects typical S/M (at press) and lactate contents (at 3 months) of washed curd low-fat 
and full-fat cheese made and analyzed under the 2006 DMI collaborative low-fat 
platform project (D.J. McMahon and J.L. Steele, pers. comm.)   
bInitial pH; adjusted after lactate addition 
 27 
 Each fermentation took place at 30ºC with a pH of 5.1 maintained over a period 
of 2 weeks with sampling at days 0, 1, 7, and 14.  With each LF and FF replicate, a low-
fat control (LFC) and FF control (FFC) at each time point were also kept at 30°C during 
the duration of the fermentation with HS sampling taking place simultaneously with the 
treatment samples.  Each condition was replicated in triplicate making a total of six batch 
runs. 
 
Cell Recovery and Enumeration 
 
Recoverable colony forming units were determined from each treatment at 0, 1, 7, 
and 14 days. Samples were serially diluted with sterile phosphate buffered saline and 
plated (0.1 ml), in duplicate, on M17 agar.  The plates were incubated anaerobically at 
30ºC for 48 hours.  Colonies were counted from plates with counts between 30 and 300 
colonies to calculate the total colony forming units in the CCE for each treatment at the 
specified time point. 
 
Headspace Solid Phase Micro-Extraction Gas  
Chromatography Mass Spectrometry Methods 
 
The CCE HS was analyzed using the following procedure:  5 ml of CCE liquid 
that had been centrifuged was added to a 20 ml HS vial along with an internal standard, 
2-methyl-3-heptanone; the vial was then capped and equilibrated for 25 minutes at 45ºC.  
Prior to testing, the vials were placed in a 300ºC oven overnight to drive off any 
contamination.  A 3-phase DVB/Carboxen/PDMS (Sigma Aldrich, St. Louis, MO) was 
inserted into the HS and the extraction of volatiles took place for 45 minutes at a 
temperature of 45ºC.  After extraction the fiber was inserted into the injection port 
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(250ºC), and was left for 10 minutes to fully desorb the metabolites.  In all cases the 
gas chromatography apparatus used was a GC-2010 Shimadzu (Kyoto, Japan) with a DB-
5ms column (length 30m, thickness 0.5µm, and diameter 0.25µm) (Agilent Technologies, 
Santa Clara, Ca) using splitless injection.  Carrier gas was helium with a flow rate of 25 
mL/min.  Oven temperature program was as follows:  hold at 40ºC for 3 minutes, 
increase temperature at a rate of 10ºC/min until 90ºC, increase temperature at a rate of 
5ºC/min until 200ºC hold at 200ºC for 10 minutes, increase temperature at a rate of 
20ºC/min until 250ºC hold at 250ºC for 10 minutes.   
Mass spectrometry (MS) analysis was carried out using a QP 2010S Shimadzu 
MS (Kyoto, Japan).  Electron impact ionization mode was used with the ionization 
voltage set at 70 eV.  The ion source temperature was 220ºC.  Data acquisition was 
performed in both scan and SIM mode 10 times per second alternating between the 2 
methods.  The scan method scanned between the range of 33-200 m/z.  The target ions of 
43, 57, 83, 114, and 142 m/z were used because they represent the target masses for 
aroma compounds associated with LF cheese.   
The analysis of the GC-MS data was performed using the deconvolution software 
AMDIS.  The spectra of peaks were compared to the NIST database to identify the 
compounds analyzed and the retention indices were cross referenced to those in the 
literature to further verify compound identity.  The program SpectConnect was used to 
conserve unidentified compounds across replicates and conditions.  The peak areas were 
normalized to that of the internal standard 2-methyl-3-heptanone.   
A variable reduction was performed to the high number of compounds detected in 
the HS analysis.  The reduction was accomplished by comparing the average 
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concentration of each compound of the treatments to their respective controls.  If the 
values did not fall in their respective standard error that compound was retained.  This 
served as a method of eliminating the compounds that were not produced in the presence 
starter culture. 
 
Metabolomic Methods 
 
Metabolomic methods were employed to monitor changes in the concentration of 
small molecules within both the CCE and the bacteria.  To measure the metabolites in the 
bacteria the following procedure was followed: A 12 ml sample of CCE was collected 
from each batch run at days 0, 1, 7, and 14.  Each sample was centrifuged for 10 minutes 
at 3000 X G at a temperature of 4ºC.  The liquid was reserved for HS and CCE 
metabolite analysis.  A 10 ml aliquot of 50 mM phosphoric buffer was then added to the 
pellet and vortexed.   After a centrifugation under the same conditions as the previous 
centrifugation, the supernatant was discarded and intracellular components of the bacteria 
extracted by adding 1.5 ml methanol at -45ºC, 0.75 ml chilled distilled water and 1.5 ml 
of -45ºC chloroform to the pellet.  An internal standard of ribotol was added to the 
sample followed by vortexing and centrifugation.  The supernatant of methanol and water 
was collected and frozen at -80ºC and dried.  The dried sample was derivitized by adding 
40 µl of MOX reagent (Thermo Fisher Scientific, Waltham, MA) and incubating for 90 
min at 40ºC.  Next 70 µl of MSTFA (Thermo Fisher Scientific, Waltham, MA) was 
added to the sample and incubated for 50 min at 40ºC. 
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In order to measure the metabolites in the CCE media the following procedures 
were followed: 100 µl of the reserved sample liquid was taken and the same extraction, 
drying, and derivitization process conducted during the bacterial metabolomics method.  
One µl of sample was injected into the GC-MS apparatus described previously 
under the following conditions:  The injection port was maintained at a temperature of 
280ºC and was splitless.  The column was the same DB-5ms column used in the HS 
analysis.  The carrier gas was helium with a column flow rate of 0.85 ml/min.  The oven 
temperature program began at 70ºC for 5 min and increased up to 280ºC at a rate of 
5ºC/min.  Electron impact ionization mode was used with the ionization voltage set at 70 
eV.  The ion source temperature was set at 200ºC.  Data acquisition was performed in the 
full scan mode (m/z 40-600).    
The raw GC-MS data was both enumerated (i.e., distinguish “true” peaks from 
noise in a chromatogram) and spectrally deconvoluted (i.e., obtain putative pure spectra 
from two overlapping peaks) by use of a freely available program AMDIS (Styczynski et 
al 2007).  Peaks were identified by standards where indicated and by NIST spectral 
database library.  The program SpectConnect was used to conserve unidentified 
compounds across replicates and conditions. The peak areas were normalized to the 
ribotol standard.  The peak areas obtained from each condition were compared for 
similarities and differences using various statistical methods.   
 
Statistical Analysis 
  
All statistical analyses were performed using SAS (v 9.1, Statistical Analysis 
Software, Cary, NC).  All missing values for each analysis (HS and metabolomics) were 
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replaced with half of the lowest value found in their respective data set (Xia and others 
2009).  The principal component analysis (PCA) was performed using Proc Princomp, 
while further analysis of compounds was accomplished via repeated measures ANOVA 
using Proc Mixed.  Replicate, treatment, day, and treatment*day were included in the 
model as fixed effects with day as the repeated measure.  The fixed effects were 
considered significant if p-values were below 0.05.  Covariance structure was 
autoregressive (1)[AR(1)].  The means were then compared using differences of least 
square means.  Differences in the means were determined significant if the Tukey 
adjusted p-value were less than 0.05. 
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RESULTS AND DISCUSSION 
 
 
Cell Recovery and Enumeration 
 
 Figure 6 shows the averaged growth curve of the bacteria in both the LF and FF 
CCE from day 0 to 14.  The growth during the fermentation process was minimal with a 
slight peak at day 7 for both the FF and LF samples.  The bacterial counts in the CCE 
during the fermentation process are similar to the counts in Cheddar cheese during the 
ripening process. 
 The growth of bacteria in the LF sample was expected to be higher than the FF 
sample due to the difference in the salt content.  Like most model systems the CCE 
model system is not perfect and is lacking the protein and fat matrix found in cheese.  
During the make procedure of CCE, water soluble compounds that could be of interest to 
bacterial growth and the aroma HS could have remained with the retentate during the 
ultrafiltering process.  The results found represent the bacterial metabolism within CCE 
and may or may not represent the bacterial metabolism in LF and FF Cheddar cheese.  
 The ripening of Cheddar cheese can take anywhere from 3 months to 2 years 
typically at a temperature of 8 to 10°C (Singh and others 2003).  The temperature of 
incubation was increased to 30°C in this study to accelerate the activity of the bacteria 
and enable the visualization of trends in aroma and metabolite profiles in the media.  This 
rise in temperature could cause a shift in the aroma and metabolite profiles away from 
Cheddar cheese. 
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Figure 6. Average growth curve during fermentation (n=3) 
 
 
Headspace Solid Phase Micro-Extraction Gas  
Chromatography Mass Spectrometry 
 
 Initial output contained 109 potential compounds that were detected in the HS of 
the samples. The variable reduction procedure reduced the compounds down to 14.  
Table 7 shows those compounds along with the CAS identification number, RI and the 
odor generally associated with each compound.  Figure 7 shows the molecular structure 
of the retained compounds.  Figure 8 shows an example of the chromatogram of a LFT 
and FFT run at day 14.  There is little difference between the FFT and the LFT 
chromatogram.  Tables A1-4 contain the average concentration as well as the standard 
deviation of each compound.   
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Table 7.  Retained compounds from headspace analysis 
 CAS 
Number RI Odor
ab 
Propan-2-one 67-64-1 552 Wood pulp, haya 
3-Methylbutanal 590-86-3 653 Green, maltya 
3-Methylbutanol 123-51-3 737 Green, alcoholica 
Heptan-2-one 110-43-0 890 Fruity, fatty, spicya 
Heptanal 111-71-7 902 Soapya 
2,6-Dimethylheptan-4-ol 108-82-7 949 mild fresh ethereal fermented yeastyb 
Benzaldehyde 100-52-7 960 strong sharp sweet bitter almond cherryb 
Dimethyl trisulfide 3658-80-8 968 Sulfurous, cabbagea 
2-Ethylhexan-1-ol 104-76-7 1025 citrus fresh floral oily sweetb 
p-Cymene 99-87-6 1027 Fresh citrus terpene woody spiceb 
2-Phenylacetaldehyde 122-78-1 1042 Rosey,  stirenea 
Nonan-2-one 821-55-6 1090 Malty, fruitya 
Isothiocyanato 
cyclohexane 1122-82-3 1238 No info 
Undecan-2-one 112-12-9 1294 Florala 
aOdor descriptions from Curioni and Bosset (2002) in cheese using GC-olfactometry 
bOdor descriptions were taken from the website www.thegoodscentscompany.com 
 
Repeated measures ANOVA 
Repeated measures ANOVA showed all of the compounds had a significant 
Treatment and Treatment*Day effect with a p-value less than 0.05 (Table 8).  3-
Methylbutanal, nonan-2-one, and undecan-2-one had an insignificant p-value for the Day 
effect.  The interactions are characterized in the concentration versus time graphs for each 
compound in Figures 9-12. Tables 9-11 show the least square mean values at each time 
period contrasting FFC and FFT, LFC and LFT, and FFT and LFT.  Tables B1-4 show  
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Figure 7. Molecular structure of retained compounds 
Propan-2-one 3-Methylbutanal 3-Methylbutanol 
Heptan-2-one 
Heptanal 
2,6-Dimethylheptan-4-ol 
 
Benzaldehyde 
 
Dimethyl trisulfide 
 2-Ethylhexan-1-ol 
p-Cymene 2-Phenylacetaldehyde 
Nonan-2-one 
Isothiocyanato cyclohexane 
Undecan-2-one 
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Figure 8. Chromatogram of a low-fat and full-fat treatment run at day 14 
 
the least square mean values for each treatment contrasting the separate time points.  The 
compared means were considered significantly different if the Tukey adjusted p-value 
was less than 0.05.    
 
Ketones 
 Propan-2-one, heptan-2-one, nonan-2-one, and undecan-2-one are ketones that 
were retained in Table 7.  Figure 1 shows that fatty acid β-oxidation could be a potential 
source of these ketones.  The graphs of concentration versus time in Figure 9 indicate that 
the fat level in the samples may be a contributing factor in the compound concentration 
for heptan-2-one and nonan-2-one due to the increased concentration in FFC and FFT 
when compared to LFC and LFT.  Each of these compounds has been found in Cheddar 
cheese (Curioni and Bosset 2002).     
Propan-2-one imparts a high wood pulp and hay odor.  The propan-2-one graph 
within Figure 9 shows propan-2-one levels starting out the same for all controls and 
treatments at day 0, as time passed the treatments stayed constant and the controls  
LF CCE 
FF CCE 
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Table 8. Headspace repeated measures ANOVA p-values from type 3 tests for fixed 
effects 
 Treatment Day Treatment*Day 
Propan-2-one 0.002 <.001 0.004 
3-Methylbutanal <.001 
 
0.546 0.004 
3-Methylbutanol 0.032 0.001 0.005 
Heptan-2-one <.001 0.018 <.001 
Heptanal 0.001 <.001 <.001 
2,6-Dimethylheptan-4-ol <.001 <.001 0.0001 
Benzaldehyde <.001 <.001 0.0022 
Dimethyl trisulfide <.001 0.009 0.016 
2-Ethylhexan-1-ol 0.001 <.001 <.001 
p-Cymene <.001 <.001 0.008 
2-Phenylacetaldehyde <.001 <.001 0.020 
Nonan-2-one 0.001 0.516 0.001 
Isothiocyanato cyclohexane <.001 
 
<.001 
 
<.001 
 Undecan-2-one 0.016 0.882 0.032 
 
 
decreased.  The propan-2-one could be reacting with other compounds in the HS, in the 
treatment samples the propan-2-one levels are being replaced by action of the starter 
culture while in the controls there is no propan-2-one production causing a decrease in 
the propan-2-one levels.  Examining the least square mean values for propan-2-one at 
each time point, there is a significant difference in the propan-2-one levels of FFC and 
FFT sample at day 14 as well as for LFC and LFT at day 7.  There does not appear to be 
a statistical difference between the FFT and LFT samples.  The least square mean values 
for each treatment indicates that there is a change over time in propan-2-one for the FFC 
and LFC samples while there is no significant change in the FFT and LFT over time. 
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Table 9. Headspace tukey adjusted p-values comparing the full-fat control and full-fat 
treatment least square means at each time point 
 FFC0 FFT0 
FFC1 
FFT1 
FFC7 
FFT7 
FFC14
FFT14 
Propan-2-one 1.000 1.000 0.071 0.024 
3-Methylbutanal 0.639 0.045 0.015 <.001 
3-Methylbutanol 1.000 1.000 0.196 0.164 
Heptan-2-one 0.676 0.999 <.001 <.001 
Heptanal 0.998 1.000 0.845 <.001 
2,6-Dimethylheptan-4-ol 1.000 0.015 <.001 <.001 
Benzaldehyde 1.000 0.899 0.195 0.002 
Dimethyl trisulfide 1.000 0.021 0.004 0.008 
2-Ethylhexan-1-ol 1.000 1.000 0.016 <.001 
p-Cymene 0.999 1.000 1.000 1.000 
2-Phenylacetaldehyde 1.000 0.584 0.993 0.732 
Nonan-2-one 0.975 1.000 0.0852 <.001 
Isothiocyanato cyclohexane 1.000 1.000 1.000 0.975 
Undecan-2-one 0.869 1.000 1.000 0.083 
For each column, the heading indicates which time and treatment are being compared 
 
Heptan-2-one imparts a high fruity and fatty odor. The heptan-2-one graph within 
Figure 9 shows heptan-2-one levels for the FFC and FFT samples starting at a slightly 
higher concentration than the LFC and LFT samples.  As time passes the controls 
decrease while the treatments increase.  The least square mean values for heptan-2-one at 
each time point indicates that there is a difference between the FFC and FFT samples and 
the LFC and LFT samples at both day 7 and 14.  There also was a difference in the FFT 
and LFT at day 0.  The least square means values for each treatment indicates a 
difference in the FFC, FFT, and LFT samples overtime, while no difference is apparent in  
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Table 10. Headspace tukey adjusted p-values comparing the low-fat control and low-
fat treatment least square means at each time point 
 LFC0 LFT0 
LFC1 
LFT1 
LFC7 
LFT7 
LFC14
LFT14 
Propan-2-one 1.000 0.992 0.032 0.139 
3-Methylbutanal 0.963 0.108 <.001 <.001 
3-Methylbutanol 1.000 1.000 0.011 0.054 
Heptan-2-one 1.000 0.985 <.001 <.001 
Heptanal 1.000 1.000 1.000 0.691 
2,6-Dimethylheptan-4-ol 0.085 <.001 <.001 <.001 
Benzaldehyde 1.000 0.311 0.075 <.001 
Dimethyl trisulfide 1.000 0.061 0.470 0.002 
2-Ethylhexan-1-ol 1.000 0.999 <.001 <.001 
p-Cymene 1.000 1.000 1.000 1.000 
2-Phenylacetaldehyde 1.000 0.168 0.035 0.004 
Nonan-2-one 1.000 1.000 0.238 0.232 
Isothiocyanato cyclohexane 1.000 <.001 <.001 <.001 
Undecan-2-one 0.999 1.000 1.000 1.000 
For each column, the heading indicates which time and treatment are being compared 
 
 
the LFC sample. 
Nonan-2-one imparts a medium malty and fruity odor.  The nonan-2-one graph 
within Figure 9 shows a similar trend as the heptan-2-one graph.  The least square mean 
values for nonan-2-one at each time point shows a difference between the FFC and the 
FFT samples at day 14, with no difference found between the LFC and LFT and the FFT 
and LFT samples at any time point.  The least square means values for each treatment 
showed no difference in the treatments and controls over time with exception of the FFC,  
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Table 11. Headspace tukey adjusted p-values comparing the full-fat treatment and low-
fat treatment least square means at each time point 
 FFT0 
LFT0 
FFT1 
LFT1 
FFT7 
LFT7 
FFT14
LFT14 
Propan-2-one 1.000 1.000 1.000 1.000 
3-Methylbutanal 1.000 1.000 1.000 1.000 
3-Methylbutanol 1.000 1.000 0.986 1.000 
Heptan-2-one 0.022 0.069 0.289 0.101 
Heptanal 0.160 0.023 0.715 <.001 
2,6-Dimethylheptan-4-ol 1.000 1.000 1.000 1.000 
Benzaldehyde 1.000 1.000 1.000 0.999 
Dimethyl trisulfide 1.000 1.000 1.000 1.000 
2-Ethylhexan-1-ol 1.000 1.000 0.018 0.618 
p-Cymene <.001 0.004 0.279 0.852 
2-Phenylacetaldehyde 1.000 1.000 0.495 0.856 
Nonan-2-one 0.084 0.476 0.619 0.196 
Isothiocyanato cyclohexane 1.000 <.001 <.001 <.001 
Undecan-2-one 0.898 0.505 0.231 0.083 
For each column, the heading indicates which time and treatment are being compared 
 
which showed a difference between the Nonan-2-one concentrations between day 0 and 
14. 
Undecan-2-one imparts a medium floral odor.  The undecan-2-one graph within 
Figure 9 shows a similar trend as the heptan-2-one and Nonan-2-one levels.  Examining 
the least square mean values for Undecan-2-one at each time point and for each treatment 
over time, there were not any interesting significant differences to report. 
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Figure 9. Graphs of concentration versus day for ketone compounds (propan-2-one, 
heptan-2-one, nonan-2-one, and undecan-2-one) 
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Figure 9. Continued 
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Aldehydes 
 3-Methylbutanal, heptanal, benzaldehyde, and 2-phenylacetaldehyde are 
aldehydes that were that were retained in Table 7.  Fatty acids and amino acids are 
potential sources for these compounds.  Figure 1 shows aldehyde production from 
unsaturated fatty acids as a result of hydroperoxide lyase.  3-methylbutanal could 
originate as a result of Strecker reactions between α-amino acids and α-keto acids  
(McSweeney and Sousa 1999).  While the compounds benzaldehyde and 2-
phenylacetaldehyde could originate from the amino acid phenylalanine (McSweeney and 
Sousa 1999).  Each of these compounds has been found in Cheddar cheese (Curioni and 
Bosset 2002).  The graphs in Figure 10 show an upward trend as time passes in the 
aldehyde concentrations in the LF and FF treatments while the controls stay at a lower 
concentration throughout time. 
 
 
Figure 10. Graphs of concentration versus day for aldehyde compounds                          
(3-methylbutanal, heptanal, benzaldehyde, and 2-phenylacetaldehyde) 
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Figure 10. Continued 
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Figure 10. Continued 
 
3-Methylbutanal imparts a high green and malty odor.  The 3-methylbutanal 
graph within Figure 10 shows an increase in the concentration of 3-methylbutanal in the 
treatments and a near zero level in the controls over time.  The least square means values 
at each time point indicate a difference between FFC and FFT at days 1, 7, and 14, with 
differences in LFC and LFT at days 7 and 14, and no differences apparent between FFT 
and LFT at any time points. The least square means values for each treatment showed no 
difference in each of the individual treatments and controls over time. 
Heptanal imparts a high soapy odor.  The heptanal graph within Figure 10 shows 
an initial difference in concentration at day 0 with an increase over time in the FFT and a 
decrease in the FFC, while the LFC and LFT remain at a low concentration.  The least 
square means values for each time point shows a difference in the FFC and FFT as well 
as the FFT and LFT all at day 14.  The least square means values for each treatment over 
time showed a change in the FFC and FFT and no change for the LFC and LFT. 
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Benzaldehyde imparts a high sharp, sweet, bitter, almond, and cherry odor.  
The benzaldehyde graph within Figure 10 shows an increase in the concentration of FFT 
and LFT samples while the FFC and LFC benzaldehyde levels remained near zero.  The 
least square mean values for each time point indicates a difference in the FFC and FFT 
and the LFC and LFT both at day 14 and no difference between the FFT and LFT 
samples.  The least square means values for each treatment over time showed a change in 
the FFT and LFT and no change for the FFC and LFC. 
2-Phenylacetaldehyde imparts a high rosey stirene odor.  The 2-
phenylacetaldehyde graph within Figure 10 shows an increase in the FFT and LFT levels 
over time with a higher amount found in the LFT sample.  The FFC and the LFC levels 
stay at a low level.  The least square mean values for each time point indicates a 
difference between the LFC and LFT samples at days 7 and 14 and no difference between 
FFC and FFT and FFT and LFT.  The least square mean value for each treatment over 
time showed a difference in the LFT 2-phenylacetaldehyde concentration and no 
difference in the FFC, LFC, and FFT overtime. 
 
Alcohols 
 3-Methylbutanol, 2,6-dimethylheptan-4-ol, and 2-ethylhexan-1-ol are alcohols 
that were retained in Table 7.  Fatty acids and amino acids are potential starting substrates 
for the production of alcohol, see Figure 1 and Table 4.  Each of these compounds has 
been found in Cheddar cheese (Curioni and Bosset 2002).  The trends in the graphs of 
concentration versus time in Figure 11 for the alcohol compounds show an increase in the 
FFT and LFT samples while the FFC and LFC samples stayed at or near zero. 
 47 
 
 
 
 
Figure 11.  Graphs of Concentration versus Day for alcohol compounds (3-
Methylbutanol, 2, 6-Dimethylheptan-4-ol, and 2-Ethylhexan-1-ol) 
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Figure 11.  Continued 
 
 
 3-Methylbutanol imparts green and alcoholic odor.  The concentration of the FFT 
and LFT increase while the FFC and LFC remain constant overtime. The least square 
means p-values for 3-methylbutanol at each time point indicates no difference between 
the FFC and FFT, LFC and LFT, and FFT and LFT samples.  The least square means of 
each treatment shows a difference in the FFC, FFT, and LFT samples over time. 
 2,6-Dimethylheptan-4-ol imparts a mild fresh, ethereal, fermented, and yeasty 
odor.  The concentration of the FFT and LFT increase while the FFC and LFC remain 
constant over time.  The least square means p-values for 2,6-Dimethylheptan-4-ol at each 
time point indicate differences between the FFC and FFT and the LFC and LFT both at 
days 7 and 14. The least square means of each treatment show a difference in the FFT 
and LFT samples over time. 
 2-Ethylhexan-1-ol imparts a medium citrus, fresh, floral, oily, and sweet odor. 
The concentration of the FFT and LFT increase while the FFC and LFC remain constant 
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over time.  The least square means p-values for 2-ethylhexan-1-ol at each time point 
indicate differences between the FFC and FFT and the LFC and LFT both at days 7 and 
14, as well as between FFT and LFT at day 7.  The least square means of each treatment 
show a difference in the FFT and LFT samples over time. 
 
Others 
 
 Dimethyl trisulfide, p-cymene, and isothiocyanato cyclohexane were categorized 
in the other group of compounds that were retained in Table 7.  The origins of p-cymene 
and isothiocyanato cyclohexane are unknown.  Their ring structure could indicate an 
aromatic amino acid such as phenylalanine as a potential source.  Dimethyl trisulfide is 
believed to be a byproduct of methionine metabolism (McSweeney and Sousa 1999).  
Dimethyl trisulfide is a well-known flavor compound found in cheese while there is no 
known source identifying p-cymene and isothiocyanato cyclohexane in Cheddar cheese. 
 
 
Figure 12.  Graphs of Concentration versus Day for other compounds (dimethyl 
trisulfide, p-cymene, and isothiocyanato cyclohexane) 
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 Figure 12. Continued 
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Dimethyl trisulfide imparts a high sulfurous and cabbage odor.  The dimethyl 
trisulfide graph within Figure 12 shows an increase in the FFT and LFT levels overtime 
while the FFC and the LFC levels stayed at a low level with the exception of LFC at day 
7.  The least square mean values for each time point indicates a difference between the 
FFC and FFT samples at days 1, 7, and 14 and LFC and LFT at day 14.  The least square 
mean value for each treatment over time showed a difference in the FFT dimethyl 
trisulfide concentration over time and no difference in the FFC, LFC, and LFT overtime.  
P-cymene imparts a high fresh, citrus, terpene, woody, and spice odor.  The p-
cymene graph within Figure 12 shows a constant low concentration in the LFC and LFT 
samples while the FFC and FFT samples decrease overtime.  This indicates that the p-
cymene could be coming from the MFGM and may be a product of bacterial metabolism 
in the media.  The least square mean values for each time point indicates a difference 
between the FFT and LFT samples at days 0 and 1.  The least square mean value for each 
treatment over time showed a difference in the FFC and FFT p-cymene concentration 
over time and no difference in the LFC and LFT samples overtime.  
  The odor imparted by isothiocyanato cyclohexane is unknown.  According to 
Rapior and others (1997) isothiocyanato cyclohexane was found in garlic and was 
hypothesized to play contributing part in the garlic odor and taste.  The isothiocyanato 
cyclohexane graph within Figure 12 shows an increase in the LFT isothiocyanato 
cyclohexane concentrations while the FFC, FFT, and LFC samples indicated 
concentrations near zero throughout time.  The least square mean values for each time 
point indicates a difference between the LFC and LFT and the FFT and the LFT samples  
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at days 1, 7, and 14.  The least square mean values for each treatment overtime showed 
a difference in only the LFT sample isothiocyanato cyclohexane concentrations.   
 
Headspace principal component analysis 
Using the 14 compounds in Table 7 a PCA was performed.  The eigenvalues of 
the correlation matrix in Table 12, as well as the eigenvalue plot in Figure 13 were used 
to determine that the first two principal components were sufficient to explain 67.4% of 
the variation in the data. 
 
Table 12. Eigenvalues of the correlation matrix for the headspace principal component 
analysis  
 Eigenvalue Difference Proportion Cumulative 
1 6.53995003 3.63820478 0.4671 0.4671 
2 2.90174525 1.73388887 0.2073 0.6744 
3 1.16785638 0.32391118 0.0834 0.7578 
4 0.84394520 0.08752693 0.0603 0.8181 
5 0.75641826 0.21303167 0.0540 0.8721 
6 0.54338659 0.11761922 0.0388 0.9110 
7 0.42576737 0.14615792 0.0304 0.9414 
8 0.27960945 0.04702536 0.0200 0.9613 
9 0.23258409 0.11072012 0.0166 0.9779 
10 0.12186397 0.05637399 0.0087 0.9867 
11 0.06548998 0.01437088 0.0047 0.9913 
12 0.05111910 0.00997367 0.0037 0.9950 
13 0.04114544 0.01202656 0.0029 0.9979 
14 0.02911888  0.0021 1.000 
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Figure 13. Eigenvalue plot for the headspace principal component analysis 
 
 
 
Figure 14. Score plots of every day combined for the headspace principal component 
analysis; FFC: plus sign; LFC: circle; FFT: square; LFT: asterisk 
Day 0: black; Day 1: blue; Day 7: red; Day 14: green 
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Figure 15.  Score plots of days 0, 1, 7, 14 for the headspace principal component analysis; 
FFC: black plus sign; LFC: green circle; FFT: blue square; LFT: red asterisk 
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The score plots in Figure 14 and 15 show little discrimination between days 0 
and 1 but days 7 and 14 there is a clear discrimination between the treatments.  At day 14, 
Prin1 separates the treatments from the controls and Prin2 separates the LFT and FFT 
samples.  The eigenvectors in Table 10 for Prin1 indicate that 3-methylbutanal, heptan-2-
one, benzaldehyde, 2-ethylhexan-1-ol, 2,6-dimethylheptan-4-ol, and 3-methylbutanol, 
using 0.3 as a cut off, play the largest role in separating the treatments from the controls.  
The eigenvectors from the same table for Prin2 indicate that heptanal, p-cymene, nonan-
2-one, and undecan-2-one, using 0.3 as a cut off, play the largest role in separating the LF 
from the FF samples.  
 
Table 13.  Eigenvectors of principal component 1 and principal component 2 for the 
headspace principal component analysis 
 Prin1 Prin2 
Propan-2-one 0.119028 0.269622 
3-Methylbutanal 0.306599 -.184472 
Heptan-2-one 0.331138 0.253856 
Heptanal 0.217257 0.398993 
Benzaldehyde 0.316766 -.017690 
p-Cymene 0.013619 0.520334 
2-Ethylhexan-1-ol 0.349095 -.182013 
2-Phenylacetaldehyde 0.274115 -.264580 
Nonan-2-one 0.289992 0.337198 
2,6-Dimethylheptan-4-ol 0.313748 -.069826 
3-Methylbutanol 0.303569 -.144666 
Dimethyl trisulfide 0.254344 -.110392 
Undecan-2-one 0.145318 0.309860 
Isothiocyanato cyclohexane 0.277395 -.218491 
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Metabolomics  
 
 
Cheddar cheese extract principal component analysis 
 
 The metabolite analysis of the CCE produced 23 compounds that were 
significantly different between the LF and FF samples.  A PCA analysis was conducted 
to reduce the variables and reveal potential trends in the data.  The eigenvalues of the 
correlation matrix in Table 14, as well as the eigenvalue plot in Figure 16 were used to 
determine that the first three principal components were sufficient to explain 65.4% of 
the variation in the data.  
The score plots in Figure 17 do not show a clear separation of the FF and LF 
samples.  It could be argued that there is a slight separation of the FF and LF samples 
along the Prin3 axis in the Prin2 versus Prin3 graph. 
 
 
Figure 16. Eigenvalue plot for the Cheddar cheese extract metabolites principal 
component analysis 
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Table 14. Eigenvalues of the correlation matrix for the Cheddar cheese extract 
metabolites principal component analysis  
 Eigenvalue Difference Proportion Cumulative 
1 7.23750326 2.71812069 0.3147 0.3147 
2 4.51938256 1.23421507 0.1965 0.5112 
3 3.28516749 0.81702165 0.1428 0.6540 
4 2.46814585 1.06742925 0.1073 0.7613 
5 1.40071660 0.39029526 0.0609 0.8222 
6 1.01042134 0.31526829 0.0439 0.8661 
7 0.69515305 0.23750313 0.0302 0.8964 
8 0.45764992 0.04618574 0.0199 0.9163 
9 0.41146418 0.02222579 0.0179 0.9342 
10 0.38923839 0.09195315 0.0169 0.9511 
11 0.29728524 0.05914323 0.0129 0.9640 
12 0.23814201 0.06819771 0.0104 0.9744 
13 0.16994430 0.02501507 0.0074 0.9817 
14 0.14492923 0.04173826 0.0063 0.9880 
15 0.10319097 0.03511190 0.0045 0.9925 
16 0.06807906 0.01800842 0.0030 0.9955 
17 0.05007064 0.03132476 0.0022 0.9977 
18 0.01874588 0.00232734 0.0008 0.9985 
19 0.01641854 0.00613542 0.0007 0.9992 
20 0.01028312 0.00519889 0.0004 0.9996 
21 0.00508423 0.00284011 0.0002 0.9999 
22 0.00224412 0.00150410 0.0001 1.000 
23 0.00074002  0.0000 1.000 
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Figure 17. Score plots of every day combined for the Cheddar cheese extract metabolites 
principal component analysis; full-fat: blue square, low-fat: black square 
 
 
Bacterial principal component analysis 
 
The metabolite analysis of the bacteria produced 9 compounds that were 
significantly different between the LF and FF samples.  A PCA analysis was conducted 
to reduce the variables and reveal potential trends in the data.  The eigenvalues of the 
correlation matrix in Table 16, as well as the eigenvalue plot in Figure 18 were used to  
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determine that the first two principal components were sufficient to explain 75.7% of 
the variation in the data.  
 
Table 15. Eigenvectors of principal component 1, principal component 2, and principal 
component 3 for the Cheddar cheese extract metabolites principal component analysis 
 Prin1 Prin2 Prin3 
Unknown 0.320069 -.153259 -.034325 
Unknown 0.015528 -.245981 -.263845 
L-Aspartic acid (3TMS) 0.116906 -.058386 -.277402 
Unknown 0.195215 -.024408 -.387903 
L-Asparagine, N,N2-bis(trimethylsilyl) 0.317572 0.096230 -.202650 
L-Glycerol-3-phosphate (4TMS) 0.230566 0.066331 -.283791 
L-Glutamine (3TMS) 0.318834 0.012027 -.055434 
Unknown 0.203090 0.148706 0.260753 
Unknown 0.224152 -.263635 0.229715 
L-Arginine (5TMS) 0.258672 -.266747 -.012258 
d-Galactose, 2,3,4,5,6-pentakis-O-
(trimethylsilyl) 0.143895 -.301076 0.204022 
Unknown 0.117400 0.293783 0.043884 
L-Tyrosine, N,O-bis(trimethylsilyl) 0.303161 0.125219 -.215036 
Unknown 0.290680 -.060093 0.247129 
Unknown 0.147292 0.210464 0.260091 
Unknown 0.128212 0.258309 0.192428 
Lactose methoxyamine 0.154922 -.273628 0.194209 
Unknown -.201651 0.123962 0.204847 
L-Isoleucine 0.074924 0.138292 0.025714 
Unknown -.034735 0.324171 -.154462 
L-Threonine (3TMS) 0.222303 0.203308 0.283653 
Unknown 0.022732 0.358250 -.121234 
Unknown 0.247036 0.209839 0.036093 
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Table 16. Eigenvalues of the correlation matrix for the bacterial metabolites principal 
component analysis 
 Eigenvalue Difference Proportion Cumulative 
1 5.33848144 3.86044966 0.5932 0.5932 
2 1.47803178 0.40695880 0.1642 0.7574 
3 1.07107298 0.53707734 0.1190 0.8764 
4 0.53399564 0.13072195 0.0593 0.9357 
5 0.40327369 0.29771860 0.0448 0.9805 
6 0.10555509 0.05344991 0.0117 0.9923 
7 0.05210518 0.03869025 0.0058 0.9981 
8 0.01341493 0.00934564 0.0015 0.9995 
9 0.00406929  0.0005 1.000 
 
 
Figure 18. Eigenvalue plot for the bacterial metabolites principal component analysis 
 
 
 The score plot of Figure 19 does not show a complete separation between the FF 
and LF samples.  Prin1 does slightly separate the FF and LF samples.  Using 0.40 as a 
cutoff, Hexadecanoic acid (1TMS), Oleic acid trimethylsilyl ester, and Octadecanoic acid  
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trimethylsilyl ester give the largest contribution to the variation of the LF and FF 
bacterial metabolites from Table 17. 
 
Table 17. Eigenvectors of principal 1 and principal 2 for the bacterial metabolites 
principal component analysis 
 Prin1 Prin2 
Pyroglutamic acid (2TMS) 0.307438 0.431379 
Alanine, phenyl-trimethylsilyl ester 0.214843 0.466161 
Citric acid (4TMS) 0.337256 0.457391 
Hexadecanoic acid (1TMS) 0.406653 -.204536 
Oleic acid, trimethylsilyl ester 0.410859 -.145816 
Octadecanoic acid, trimethylsilyl ester 0.402848 -.256275 
Glycine (2TMS) 0.136623 0.224317 
Unknown 0.397103 -.135434 
Unknown 0.269756 -.435849 
 
 
 
Figure 19. Score plots of every day combined for the bacterial metabolites principal 
component analysis; full-fat: blue square, low-fat: black square  
 
 62 
CONCLUSIONS 
 
 
The bacterial growth during the fermentation was minimal.  The cell counts 
resembled the counts found in ripening Cheddar cheese of around 108 CFU per g or ml.  
The lack of growth could be attributed to the lack of growth substrates as well as the salt 
concentrations found in both the LF and FF CCE.  The lack of growth indicates that the 
conditions within the CCE successfully mirrored ripening cheese. 
Propan-2-one, heptan-2-one, 3-methylbutanal, heptanal, benzaldehyde, 2-
ethylhexan-1-ol, and dimethyl trisulfide were present at a higher concentration in the FFT 
and LFT when compared to their respective controls.  Thus, the presence of these 
compounds can be attributed to the action of the starter cultures in the samples.  This 
shows that the metabolic action of the starter culture Lactococcus lactis does alter the HS 
profile in CCE and potentially Cheddar cheese.   
Differences between the FF and LF samples were seen in the heptan-2-one and p-
cymene concentrations early in the fermentation process with a higher concentration 
found in the FF compared to the LF.  The early difference indicates that this difference 
could be due to the FF and LF conditions in the CCE media, primarily the fat or MFGM 
level.  Other differences in the heptanal, 2-ethylhexan-1-ol, and cyclohexyl isothicyanate 
concentrations, between the FFT and LFT samples, were detected later in the 
fermentation process.  This indicates that differences were brought about by the growth 
of starter cultures in there respective medias.  The media conditions of FF and LF affects 
the heptanal, 2-ethylhexan-1-ol, and cyclohexyl isothiocyanate levels as a result of starter 
culture metabolism.  These findings further substantiate the credibility of the second LF 
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theory that states the microbial physiology itself, and thus overall metabolism, is 
altered by differences in the physico-chemical environment in ways that affect the 
production of flavor and aroma active metabolites.  These compounds could play a 
contributing role in the off flavors found in LF Cheddar cheese.  
 The HS PCA provided a separation of the FFC, LFC, FFT, and LFT based on 
both FF versus LF and control versus treatment.  The compounds found to be most 
responsible for the variation between FF and LF samples are heptanal, p-cymene, Nonan-
2-one, and Undecan-2-one.  Examining the graphs of concentration versus time for each 
of these compounds, at day 0 the FF samples have a higher concentration of these 
compounds when compared to the LF samples.  The compounds found to be the most 
responsible for the variation between the control and treatment samples are 3-
methylbutanal, heptan-2-one, benzaldehyde, 2-Ethylhexan-1-ol, 2,6-Dimethylheptan-4-
ol, and 3-methylbutanol.  An explanation of this separation could be due to the significant 
differences found between the treatments and controls in all these compounds except 2,6-
Dimethylheptan-4-ol. 
 The PCA metabolomic results for both the bacteria and CCE metabolites did not 
produce a clear separation between the FF and LF samples.  This could be due to the 
sensitivity of the method or the metabolites in the samples are not sufficiently different 
enough to produce a separation.  Perhaps a larger sample size would have produced a 
better separation of the treatments or the addition of another variable like different strain 
of starter culture or another incubation temperature.  The two-week incubation time could 
be too short and a longer time maybe needed to produce a separation between the FF and 
LF samples. 
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 Differences in the HS of the FF and LF samples occurred as a result of the 
metabolism of the starter cultures at 30°C, further tests are needed to verify if similar 
differences occur at ripening temperatures.  Other future tests could involve sensory 
analysis of the compounds found to be different in the FFT and the LFT in a Cheddar 
cheese sample to verify if the differences in concentration can be detected.   
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Table A1. Headspace full-fat control means and standard deviation 
  FFC 0 FFC 1 FFC 7 FFC 14 
Propan-2-one 2.8193 1.0412 2.2373 0.4978 0.6677 0.0879 0.1503 0.0901 
3-Methylbutanal 0.0348 0.0340 0.0269 0.0235 0.0088 0.0074 0.0003 0.0001 
3-Methylbutanol 0.0311 0.0530 0.0051 0.0082 0.0004 0.0001 0.0095 0.0159 
Heptan-2-one 0.1478 0.0379 0.0926 0.0186 0.0162 0.0137 0.0153 0.0010 
Heptanal 0.0304 0.0107 0.0235 0.0053 0.0080 0.0010 0.0083 0.0006 
2,6-Dimethylheptan-4-ol 0.0039 0.0030 0.0034 0.0027 0.0004 0.0001 0.0032 0.0026 
Benzaldehyde 0.0225 0.0095 0.0251 0.0140 0.0265 0.0028 0.0332 0.0149 
Dimethyl trisulfide 0.0021 0.0028 0.0003 0.0001 0.0004 0.0001 0.0020 0.0030 
2-Ethylhexan-1-ol 0.1940 0.2550 0.0493 0.0535 0.0380 0.0396 0.0553 0.0775 
p-Cymene 0.0073 0.0027 0.0053 0.0010 0.0021 0.0014 0.0016 0.0012 
2-Phenylacetaldehyde 0.0298 0.0142 0.0260 0.0038 0.0341 0.0050 0.0456 0.0187 
Nonan-2-one 0.0501 0.0261 0.0299 0.0061 0.0165 0.0045 0.0031 0.0049 
Isothiocyanato 
cyclohexane 0.0008 0.0003 0.0007 0.0002 0.0008 0.0003 0.0006 0.0002 
Undecan-2-one 0.0039 0.0060 0.0137 0.0054 0.0128 0.0050 0.0031 0.0050 
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Table A2. Headspace low-fat control means and standard deviation 
  LFC 0 LFC 1 LFC 7 LFC 14 
Propan-2-one 2.0343 0.1991 2.6004 1.1410 0.4241 0.1558 0.1811 0.0577 
3-Methylbutanal 0.0275 0.0146 0.0129 0.0092 0.0094 0.0158 0.0050 0.0081 
3-Methylbutanol 0.0027 0.0041 0.0010 0.0013 0.0014 0.0018 0.0003 0.0000 
Heptan-2-one 0.0521 0.0046 0.0269 0.0212 0.0126 0.0052 0.0124 0.0019 
Heptanal 0.0110 0.0032 0.0070 0.0039 0.0043 0.0015 0.0044 0.0013 
2,6-Dimethylheptan-4-ol 0.0003 0.0001 0.0010 0.0013 0.0003 0.0001 0.0003 0.0000 
Benzaldehyde 0.0166 0.0079 0.0172 0.0157 0.0226 0.0121 0.0171 0.0015 
Dimethyl trisulfide 0.0015 0.0020 0.0010 0.0013 0.0584 0.1006 0.0003 0.0000 
2-Ethylhexan-1-ol 0.2207 0.2198 0.0253 0.0414 0.0524 0.0617 0.0023 0.0034 
p-Cymene 0.0010 0.0011 0.0010 0.0013 0.0003 0.0001 0.0003 0.0000 
2-Phenylacetaldehyde 0.0249 0.0150 0.0161 0.0118 0.0327 0.0139 0.0278 0.0039 
Nonan-2-one 0.0078 0.0063 0.0044 0.0053 0.0003 0.0001 0.0003 0.0000 
Isothiocyanato 
cyclohexane 0.0005 6.3 E
-6 0.0007 0.0002 0.0005 5.6 E-6 0.0007 0.0002 
Undecan-2-one 0.0090 0.0095 0.0041 0.0048 0.0003 0.0001 0.0003 0.0000 
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Table A3. Headspace full-fat treatment means and standard deviation 
  FFT 0 FFT 1 FFT 7 FFT 14 
Propan-2-one 2.5820 0.5384 2.1981 0.3788 2.3223 0.1265 2.0456 0.2968 
3-Methylbutanal 0.1819 0.0396 0.9097 0.3972 1.0187 1.0887 2.0133 0.2830 
3-Methylbutanol 0.0178 0.0151 0.0603 0.0278 0.5484 0.1084 0.5748 0.2532 
Heptan-2-one 0.1117 0.0090 0.1098 0.0187 0.1583 0.0238 0.1937 0.0439 
Heptanal 0.0253 0.0029 0.0254 0.0037 0.0169 0.0111 0.0479 0.0128 
2,6-Dimethylheptan-4-ol 0.0053 0.0043 0.0647 0.0153 0.5286 0.5357 0.5821 0.6052 
Benzaldehyde 0.0168 0.0037 0.0518 0.0224 0.1007 0.0050 0.3653 0.2727 
Dimethyl trisulfide 0.0019 0.0016 0.0271 0.0164 0.0503 0.0082 0.0856 0.0437 
2-Ethylhexan-1-ol 0.0520 0.0521 0.1361 0.1067 1.0521 0.3465 1.9527 0.4239 
p-Cymene 0.0064 0.0010 0.0048 0.0007 0.0029 0.0005 0.0020 0.0014 
2-Phenylacetaldehyde 0.0300 0.0009 0.0915 0.0520 0.0784 0.0616 0.1481 0.0939 
Nonan-2-one 0.0364 0.0077 0.0336 0.0036 0.0505 0.0169 0.0587 0.0205 
Isothiocyanato 
cyclohexane 0.0009 0.0003 0.0007 0.0002 0.0008 0.0005 0.0015 0.0016 
Undecan-2-one 0.0122 0.0082 0.0125 0.0017 0.0157 0.0062 0.0194 0.0088 
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Table A4. Headspace low-fat treatment means and standard deviation 
  LFC 0 LFC 1 LFC 7 LFC 14 
Propan-2-one 2.6604 1.0035 2.0242 0.1085 2.2532 0.1690 1.6794 0.7391 
3-Methylbutanal 0.1672 0.0686 0.5540 0.1110 2.3460 2.5234 2.5241 0.4880 
3-Methylbutanol 0.0021 0.0023 0.0393 0.0137 0.7903 0.6432 0.6638 0.5114 
Heptan-2-one 0.0421 0.0127 0.0494 0.0111 0.1110 0.0040 0.1365 0.0225 
Heptanal 0.0102 0.0033 0.0058 0.0018 0.0069 0.0010 0.0145 0.0027 
2,6-Dimethylheptan-4-ol 0.0047 0.0006 0.0827 0.0145 0.4501 0.1165 0.4048 0.2072 
Benzaldehyde 0.0137 0.0039 0.0389 0.0159 0.1065 0.0484 0.2086 0.0922 
Dimethyl trisulfide 0.0020 0.0009 0.0290 0.0163 0.0353 0.0045 0.0633 0.0179 
2-Ethylhexan-1-ol 0.1139 0.1440 0.2606 0.1660 1.6088 0.5951 2.4907 0.6229 
p-Cymene 0.0009 0.0006 0.0003 0.0001 0.0003 0.0000 0.0004 0.0001 
2-Phenylacetaldehyde 0.0222 0.0079 0.0578 0.0321 0.2798 0.2494 0.3254 0.1251 
Nonan-2-one 0.0023 0.0026 0.0097 0.0082 0.0288 0.0029 0.0290 0.0184 
Isothiocyanato 
cyclohexane 0.0006 0.0002 0.0096 0.0024 0.0390 0.0054 0.0524 0.0100 
Undecan-2-one 0.0043 0.0037 0.0013 0.0016 0.0020 0.0028 0.0031 0.0047 
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Appendix B: Headspace Comparison of Least Square Means Overtime 
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Table B1. Headspace tukey adjusted p-values comparing full-fat control least square 
means overtime 
 FFC0 
FFC1 
FFC0 
FFC7 
FFC0 
FFC14 
FFC1 
FFC7 
FFC1 
FFC14 
FFC7 
FFC14 
Propan-2-one 0.993 0.007 0.001 0.117 0.009 0.998 
3-Methylbutanal 1.000 1.000 0.163 1.000 1.000 0.770 
3-Methylbutanol 1.000 1.000 1.000 0.001 1.000 1.000 
Heptan-2-one 0.024 <.001 <.001 1.000 0.004 1.000 
Heptanal 0.830 0.002 0.005 0.018 0.086 1.000 
2,6-Dimethylheptan-4-ol 1.000 0.413 1.000 0.551 1.000 0.608 
Benzaldehyde 1.000 1.000 1.000 1.000 1.000 1.000 
Dimethyl trisulfide 0.999 0.999 1.000 1.000 1.000 1.000 
2-Ethylhexan-1-ol 0.997 1.000 1.000 1.000 1.000 1.000 
p-Cymene 0.501 0.001 <.001 0.027 0.019 1.000 
2-Phenylacetaldehyde 1.000 1.000 1.000 1.000 0.998 1.000 
Nonan-2-one 0.407 0.058 0.004 0.893 0.234 0.900 
Isothiocyanato cyclohexane 1.000 0.998 1.000 1.000 1.000 1.000 
Undecan-2-one 0.284 0.681 1.000 1.000 0.426 0.290 
For each column, the heading indicates which time and treatment are being compared.   
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Table B2. Headspace tukey adjusted p-values comparing low-fat control least square 
means overtime 
 LFC0 
LFC1 
LFC0 
LFC7 
LFC0 
LFC14 
LFC1 
LFC7 
LFC1 
LFC14 
LFC7 
LFC14 
Propan-2-one 0.995 0.086 0.029 0.007 0.002 1.000 
3-Methylbutanal 1.000 0.541 0.396 0.980 0.860 1.000 
3-Methylbutanol 1.000 1.000 1.000 1.000 1.000 1.000 
Heptan-2-one 0.831 0.445 0.506 1.000 0.998 1.000 
Heptanal 0.998 0.999 1.000 1.000 1.000 1.000 
2,6-Dimethylheptan-4-ol 0.998 1.000 1.000 0.996 0.999 1.000 
Benzaldehyde 0.999 1.000 1.000 0.905 0.999 1.000 
Dimethyl trisulfide 1.000 0.996 0.999 0.983 1.000 0.736 
2-Ethylhexan-1-ol 0.961 0.999 0.997 1.000 1.000 1.000 
p-Cymene 1.000 0.999 1.000 0.999 0.999 1.000 
2-Phenylacetaldehyde 0.968 1.000 1.000 0.609 0.843 1.000 
Nonan-2-one 1.000 0.999 0.999 1.000 1.000 1.000 
 Isothiocyanato cyclohexane 0.996 1.000 0.999 0.985 1.000 0.983 
Undecan-2-one 0.976 0.707 0.784 0.997 0.999 1.000 
For each column, the heading indicates which time and treatment are being compared. 
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Table B3. Headspace tukey adjusted p-values comparing full-fat treatment least square 
means overtime 
 FFT0 
FFT1 
FFT0 
FFT7 
FFT0 
FFT14 
FFT1 
FFT7 
FFT1 
FFT14 
FFT7 
FFT14 
Propan-2-one 0.999 1.000 0.996 1.000 1.000 1.000 
3-Methylbutanal 0.996 0.999 0.789 1.000 1.000 0.999 
3-Methylbutanol 1.000 0.080 0.105 0.027 0.099 1.000 
Heptan-2-one 1.000 0.221 0.003 0.067 0.002 0.988 
Heptanal 1.000 0.803 0.004 0.559 0.002 <.001 
2,6-Dimethylheptan-4-ol 0.020 <.001 <.001 0.590 0.655 1.000 
Benzaldehyde 0.250 0.014 <.001 0.813 0.013 0.230 
Dimethyl trisulfide 0.348 0.073 0.028 1.000 0.996 1.000 
2-Ethylhexan-1-ol 1.000 <.001 <.001 <.001 <.001 <.001 
p-Cymene 0.783 0.039 0.005 0.567 0.173 0.997 
2-Phenylacetaldehyde 0.639 0.963 0.290 1.000 0.999 0.971 
Nonan-2-one 1.000 0.947 0.550 0.659 0.316 0.999 
 Isothiocyanato cyclohexane 1.000 1.000 1.000 1.000 1.000 1.000 
Undecan-2-one 0.999 1.000 1.000 1.000 0.958 0.963 
For each column, the heading indicates which time and treatment are being compared. 
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Table B4. Headspace tukey adjusted p-values comparing low-fat treatment least square 
means overtime 
 LFT0 
LFT1 
LFT0 
LFT7 
LFT0 
LFT14 
LFT1 
LFT7 
LFT1 
LFT14 
LFT7 
LFT14 
Propan-2-one 0.984 0.999 0.699 1.000 1.000 0.994 
3-Methylbutanal 0.999 0.814 0.616 0.999 0.992 1.000 
3-Methylbutanol 1.000 0.002 0.027 <.001 0.021 0.999 
Heptan-2-one 1.000 0.013 0.001 0.008 0.001 0.820 
Heptanal 0.994 1.000 0.999 1.000 0.758 0.716 
2,6-Dimethylheptan-4-ol 0.032 0.001 0.001 0.569 0.821 1.000 
Benzaldehyde 0.329 0.005 <.001 0.392 0.031 0.861 
Dimethyl trisulfide 0.483 0.272 0.099 1.000 0.999 1.000 
2-Ethylhexan-1-ol 0.997 <.001 <.001 <.001 <.001 <.001 
p-Cymene 1.000 1.000 1.000 1.000 1.000 1.000 
2-Phenylacetaldehyde 0.769 0.005 0.001 0.175 0.066 1.000 
Nonan-2-one 0.999 0.245 0.291 0.481 0.684 1.000 
 Isothiocyanato cyclohexane <.001 <.001 <.001 <.001 <.001 0.966 
Undecan-2-one 0.999 1.000 1.000 1.000 1.000 1.000 
For each column, the heading indicates which time and treatment are being compared. 
 
 
